Corrigendum to: Antiproliferative Activity of Cephalotaxus Esters: Overcoming Chemoresistance.
AI interpretation is pending for this paper.
Open original publication →What the AI sees
Not AI summarized yet.
Research significance
Pending deeper interpretation.
Source abstract
It has been brought to our attention that a deceased individual was inadvertently included as a co-author of this article. In line with publishing policies and ethical guidelines, the corresponding author has been advised to remove their name from the author list. Their valuable contributions to the work will be appropriately recognized in the Acknowledgements section. The original article can be found online at https://benthamscience.com/public/article/144076 Details of the correction: • Original: 1HTS Core Facility - Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA; 2Molecular Pharmacology Program - Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA; 3Department of Medicine - Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA; 4Molecular Biology Program, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA; 5Deceased; 6Department of Analytical Chemistry, C16 Biosciences, New York, NY 10019, USA; 7Automation and Workflow Solutions, Molecular Devices, San Jose, CA 95134, USA; 8Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; 9Screening Discovery Platform, Institut Pasteur Korea, Seongnamsi, Gyeonggido, 13488, Republic of Korea; 10Office of the CMO, Cellectis Inc, New York, NY 10016, USA; 11Office of the CEO, Keren Therapeutics, New York, NY 10583, USA • Corrected: 1HTS Core Facility - Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA; 2Molecular Pharmacology Program - Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA; 3Department of Medicine - Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA; 4Molecular Biology Program, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA; 5Department of Analytical Chemistry, C16 Biosciences, New York, NY 10019, USA; 6Automation and Workflow Solutions, Molecular Devices, San Jose, CA 95134, USA; 7Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; 8Screening Discovery Platform, Institut Pasteur Korea, Seongnam-si, Gyeonggi-do, 13488, Republic of Korea; 9Office of the CMO, Cellectis Inc, New York, NY 10016, USA; 10Office of the CEO, Keren Therapeutics, New York, NY 10583, USA • Original: ACKNOWLEDGEMENTS The authors thank Drs Eric C. Holland (Fred Hutchinson Cancer Center, Seattle, USA), David A. Scheinberg (MSKCC, New York, USA), and Jean-Pierre Marie (University of Paris, France) for sharing valuable cells. They also thank members of the MSKCC Molecular Cytology Core Facility for their help in confocal imaging experiments. • Corrected: ACKNOWLEDGEMENTS We are indebted to the late Professor David Y Gin (1967-2011) for his major contribution to this work by making available to us these invaluable cephalotaxus ester derivatives. This work is dedicated to him for all his contributions to the field of medicinal chemistry using natural products. We thank Drs. Eric C. Holland (Fred Hutchinson Cancer Center, Seattle, USA), David A. Scheinberg (MSKCC, New York, USA), and Jean-Pierre Marie (University of Paris, France) for sharing valuable cells. We also thank members of the MSKCC Molecular Cytology Core Facility for their help in confocal imaging experiments. We apologize for any inconvenience caused.